Behget's disease is more common and widespread than was previously thought, especially in the Middle East, the Mediterranean countries, and Japan (Abdalla and Bahgat, I973) . Loss of visual acuity is one of the most frequent, as well as the most serious, of its varied manifestations. Total blindness is often inevitable and the rate of deterioration of sight may be used as a criterion for assessing the effectiveness of any treatment (Mamo, I970 Three daily doses of chlorambucil (Leukeran) 6 to 8 mg were taken after meals for 3 months and for a further 3 months 6 mg were given on alternate days (Perkins, I974 In all cases the uveitis quietened down and the flare and cells in the anterior chamber disappeared. Remission was obtained in all cases of posterior uveitis and neuroretinitis. The vascular sheathing of the retina remained stationary, and no further ocular damage was recorded. In none of our patients did vision deteriorate even in the two who were followed-up for 2 years. In some the visual acuity improved (Tables III and IV) .
In two patients (Cases i and 2) there were mild recurrences of posterior uveitis 8 to io months after the treatment with chlorambucil had stopped, but the inflammation soon disappeared with a small dose of corticosteroids and another chlorambucil regimen for 3 months. All patients showed a definite improvement of aphthous oral lesions, skin lesions, thrombophlebitis, and other manifestations. There were occasional recurrences of mucocutaneous lesions in some cases, but these were milder and less numerous than before treatment with chlorambucil.
The drug was well tolerated in all patients except one who complained of a mild epigastric buming and fatigue.
Discussion
Cytotoxic drugs are administered in inflammatory disease of uncertain cause because of their immunosuppressive properties. These drugs interrupt nucleic acid and protein synthesis, thereby inhibiting various immune responses at different stages (Steinberg, Plotz, Wolff, Wong, Agus, and Decker, 1972) . The chemotherapeutic activity of chloram- (Abdalla and Bahgat, I973; Godfrey and others, 1974; Mamo and Azzam, 1970; Pezzi, 1972; Smulders and Oosterhuis, 1975) .
Our results confirm those of other authors, although the protocol in some studies was different. In our work there was no control group, each patient serving as his own control. The assessment of the effect of the drug was made individually by comparing the course of the disease before and after treatment.
As has been shown (Mamo, 1970) , loss of visual acuity occurs on average after 3 to 6 years of onset of ocular symptoms. The steroids have only a mild delaying effect upon the rate of visual loss, so this information acts as a base line in the assessment of a new treatment.
All patients who were treated with chlorambucil in our study improved. They all had a long-lasting remission without serious toxic reactions or sideeffects of the drug. Two patients suffered benign relapses of posterior uveitis 8 to i o months after the treatment had been stopped.
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